| Literature DB >> 30342710 |
Garrett Teskey1, Rachel Abrahem1, Ruoqiong Cao2, Karo Gyurjian3, Hicret Islamoglu4, Mariana Lucero1, Andrew Martinez1, Erik Paredes1, Oscar Salaiz3, Brittanie Robinson3, Vishwanath Venketaraman5.
Abstract
Glutathione (GSH), often referred to as "the master antioxidant," participates not only in antioxidant defense systems, but many metabolic processes, and therefore its role cannot be overstated. GSH deficiency causes cellular risk for oxidative damage and thus as expected, GSH imbalance is observed in a wide range of pathological conditions including tuberculosis (TB), HIV, diabetes, cancer, and aging. Consequently, it is not surprising that GSH has attracted the attention of biological researchers and pharmacologists alike as a possible target for medical intervention. Here, we discuss the role GSH plays amongst these pathological conditions to illuminate how it can be used as a marker for human disease.Entities:
Keywords: Ageing; Cancer; Diabetes; Glutathione; HIV; Tuberculosis
Mesh:
Substances:
Year: 2018 PMID: 30342710 DOI: 10.1016/bs.acc.2018.07.004
Source DB: PubMed Journal: Adv Clin Chem ISSN: 0065-2423 Impact factor: 5.394